150 related articles for article (PubMed ID: 21841768)
1. Quantitative image analysis in the assessment of diffuse large B-cell lymphoma.
Chabot-Richards DS; Martin DR; Myers OB; Czuchlewski DR; Hunt KE
Mod Pathol; 2011 Dec; 24(12):1598-605. PubMed ID: 21841768
[TBL] [Abstract][Full Text] [Related]
2. Nodal diffuse large B-cell lymphomas in children and adolescents: immunohistochemical expression patterns and c-MYC translocation in relation to clinical outcome.
Gualco G; Weiss LM; Harrington WJ; Bacchi CE
Am J Surg Pathol; 2009 Dec; 33(12):1815-22. PubMed ID: 19816150
[TBL] [Abstract][Full Text] [Related]
3. Computer-driven quantitative image analysis in the assessment of tumor cell and T cell features in diffuse large B cell lymphomas.
Gaudio F; Tamma R; Ingravallo G; Perrone T; Laddaga FE; De Candia M; Maiorano E; Ribatti D; Specchia G
Ann Hematol; 2018 Apr; 97(4):663-668. PubMed ID: 29362889
[TBL] [Abstract][Full Text] [Related]
4. Poor outcome in patients with diffuse large B-cell lymphoma is associated with high percentage of bcl-2 and Ki 67-positive tumor cells.
Jovanović MP; Jaković L; Bogdanović A; Marković O; Martinović VC; Mihaljević B
Vojnosanit Pregl; 2009 Sep; 66(9):738-43. PubMed ID: 19877554
[TBL] [Abstract][Full Text] [Related]
5. Comparison of evaluation techniques, including digital image analysis, for MYC protein expression by immunohistochemical stain in aggressive B-cell lymphomas.
Hupp M; Williams S; Dunnette B; Tessier KM; Courville EL
Hum Pathol; 2019 Jan; 83():124-132. PubMed ID: 30172916
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the methods for measuring the Ki-67 labeling index in adrenocortical carcinoma: manual versus digital image analysis.
Yamazaki Y; Nakamura Y; Shibahara Y; Konosu-Fukaya S; Sato N; Kubota-Nakayama F; Oki Y; Baba S; Midorikawa S; Morimoto R; Satoh F; Sasano H
Hum Pathol; 2016 Jul; 53():41-50. PubMed ID: 26980031
[TBL] [Abstract][Full Text] [Related]
7. Coexpression of MYC and BCL-2 predicts prognosis in primary gastrointestinal diffuse large B-cell lymphoma.
Xia B; Zhang L; Guo SQ; Li XW; Qu FL; Zhao HF; Zhang LY; Sun BC; You J; Zhang YZ
World J Gastroenterol; 2015 Feb; 21(8):2433-42. PubMed ID: 25741152
[TBL] [Abstract][Full Text] [Related]
8. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
[TBL] [Abstract][Full Text] [Related]
9. Both c-Myc and Ki-67 expression are predictive markers in patients with extranodal NK/T-cell lymphoma, nasal type: a retrospective study in China.
Huang X; Sun Q; Fu H; Zhou X; Guan X; Wang J
Pathol Res Pract; 2014 Jun; 210(6):351-6. PubMed ID: 24642368
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of nuclear factor κB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy.
Shin HC; Seo J; Kang BW; Moon JH; Chae YS; Lee SJ; Lee YJ; Han S; Seo SK; Kim JG; Sohn SK; Park TI
Korean J Intern Med; 2014 Nov; 29(6):785-92. PubMed ID: 25378977
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.
Hoster E; Rosenwald A; Berger F; Bernd HW; Hartmann S; Loddenkemper C; Barth TF; Brousse N; Pileri S; Rymkiewicz G; Kodet R; Stilgenbauer S; Forstpointner R; Thieblemont C; Hallek M; Coiffier B; Vehling-Kaiser U; Bouabdallah R; Kanz L; Pfreundschuh M; Schmidt C; Ribrag V; Hiddemann W; Unterhalt M; Kluin-Nelemans JC; Hermine O; Dreyling MH; Klapper W
J Clin Oncol; 2016 Apr; 34(12):1386-94. PubMed ID: 26926679
[TBL] [Abstract][Full Text] [Related]
12. C-MYC overexpression predicts aggressive transformation and a poor outcome in mucosa-associated lymphoid tissue lymphomas.
Huang W; Guo L; Liu H; Zheng B; Ying J; Lv N
Int J Clin Exp Pathol; 2014; 7(9):5634-44. PubMed ID: 25337204
[TBL] [Abstract][Full Text] [Related]
13. Ki 67 assessment in breast cancer in an Egyptian population: a comparative study between manual assessment on optical microscopy and digital quantitative assessment.
Ayad E; Soliman A; Anis SE; Salem AB; Hu P; Dong Y
Diagn Pathol; 2018 Aug; 13(1):63. PubMed ID: 30153851
[TBL] [Abstract][Full Text] [Related]
14. Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer.
Rexhepaj E; Jirstrom K; O'Connor DP; O'Brien SL; Landberg G; Duffy MJ; Brennan DJ; Gallagher WM
BMC Cancer; 2010 Nov; 10():639. PubMed ID: 21092276
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy.
Liu Z; Xu-Monette ZY; Cao X; Manyam GC; Wang X; Tzankov A; Xia Y; Li X; Visco C; Sun R; Zhang L; Montes-Moreno S; Dybkær K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Parsons BM; Møller MB; Piris MA; Winter JN; O'Malley DP; Medeiros LJ; Young KH
Mod Pathol; 2015 Oct; 28(10):1297-314. PubMed ID: 26248897
[TBL] [Abstract][Full Text] [Related]
16. Comparison of digital image analysis and visual scoring of KI-67 in prostate cancer prognosis after prostatectomy.
Desmeules P; Hovington H; Nguilé-Makao M; Léger C; Caron A; Lacombe L; Fradet Y; Têtu B; Fradet V
Diagn Pathol; 2015 Jun; 10():67. PubMed ID: 26070608
[TBL] [Abstract][Full Text] [Related]
17. CD30 expression and its correlation with MYC and BCL2 in de novo diffuse large B-cell lymphoma.
Gong QX; Wang Z; Liu C; Li X; Lu TX; Liang JH; Xu W; Li JY; Zhang ZH
J Clin Pathol; 2018 Sep; 71(9):795-801. PubMed ID: 29666157
[TBL] [Abstract][Full Text] [Related]
18. Low rather than high Ki-67 protein expression is an adverse prognostic factor in diffuse large B-cell lymphoma.
Hasselblom S; Ridell B; Sigurdardottir M; Hansson U; Nilsson-Ehle H; Andersson PO
Leuk Lymphoma; 2008 Aug; 49(8):1501-9. PubMed ID: 18766962
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and clinicopathologic features of CD30-positive de novo diffuse large B-cell lymphoma in Chinese patients: a retrospective study of 232 cases.
Gong QX; Lu TX; Liu C; Wang Z; Liang JH; Xu W; Li JY; Zhang ZH; Chen Q
Int J Clin Exp Pathol; 2015; 8(12):15825-35. PubMed ID: 26884853
[TBL] [Abstract][Full Text] [Related]
20. Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I/II melanoma.
Nielsen PS; Riber-Hansen R; Jensen TO; Schmidt H; Steiniche T
Mod Pathol; 2013 Mar; 26(3):404-13. PubMed ID: 23174936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
